Search Results
Imugene Investor Webinar | FDA IND Clearance for onCARlytics
Investor Presentation post ASX news: Imugene and Eureka Therapeutics onCARlytics Collaboration
Imugene Investor Webinar | Acquisition of License for Azer-Cel Cell Therapy
Imugene (ASX:IMU) | Webinar with Leslie Chong | 07/11/24
'The Why' | Imugene, Developing Cancer Immunotherapies ASX: IMU
Imugene (ASX: IMU) - Discussing IMU's 2022 Biotech Opportunity
Imugene Investor Presentation | Non-deal Roadshow 2023 Australia
First Patient dosed in Imugene's PD1-Vaxx Combination Trial
Imugene Licenses Potential for First “Allo” CAR T to be Approved in Blood Cancer
Imugene + Celularity Announce an Exclusive Strategic Partnership to Develop a Novel Oncolytic Virus.
Imugene forges development path of immunotherapies and cancer-killing virus
IMUGENE DOSES FIRST PATIENT IN VAXINIA PHASE 1 TRIAL
